Intravenous Solutions Market Size, Share & Trends Report

Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (TPN, PPN), By Nutrients (Carbohydrates, Single Dose Amino Acid Solution, Parenteral Lipid Emulsion), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Feb, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-137-5
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 114

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                         1.1.1. Type
                         1.1.2. Nutrients
                         1.1.3. Regional scope
                         1.1.4. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                         1.3.1. Purchased database
                         1.3.2. GVR’s internal database
                         1.3.3. Secondary sources
                         1.3.4. Primary research
                         1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                         1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                         1.6.1. Commodity flow analysis (Model 1)
                              1.6.1.1. Approach 1: Commodity flow approach
                         1.6.2. Volume price analysis (Model 2)
                              1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                         1.9.1. Objective 1:
                         1.9.2. Objective 2:
                         1.9.3. Objective 3:
                         1.9.4. Objective 4:
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Intravenous (IV) Solutions Market Variables, Trends & Scope
                    3.1. Penetration & Growth Prospect Mapping
                    3.2. Industry Value Chain Analysis
                         3.2.1. Reimbursement framework
                    3.3. Market Dynamics
                         3.3.1. Market driver analysis
                         3.3.2. Market restraint analysis
                         3.3.3. Industry challenges
                    3.4. Intravenous (IV) solutions Market Analysis Tools
                         3.4.1. Industry Analysis - Porter’s
                              3.4.1.1. Supplier power
                              3.4.1.2. Buyer power
                              3.4.1.3. Substitution threat
                              3.4.1.4. Threat of new entrant
                              3.4.1.5. Competitive rivalry
                         3.4.2. PESTEL Analysis
                              3.4.2.1. Political landscape
                              3.4.2.2. Technological landscape
                              3.4.2.3. Economic landscape
                         3.4.3. Major Deals & Strategic Alliances Analysis
                         3.4.4. Market Entry Strategies
Chapter 4. Intravenous (IV) Solutions Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Definitions and Scope
                    4.3. Intravenous (IV) solutions Market Share, 2020 & 2028
                    4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
                         4.4.1. Total Parenteral Nutrition (TPN)
                         4.4.2. Peripheral Parenteral Nutrition (PPN)
Chapter 5. Intravenous (IV) Solutions Market: Nutrients Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Definitions and Scope
                    5.3. Intravenous (IV) solutions Market Share, 2020 & 2028
                    5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
                         5.4.1. Carbohydrates
                         5.4.2. Single Dose Amino Acid Solution
                         5.4.3. Vitamins & Minerals (Salt and electrolyte)
                         5.4.4. Parenteral Lipid Emulsion
                         5.4.5. Others
Chapter 6. Intravenous (IV) Solutions Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Dashboard
                    6.2. Regional Market Share Analysis, 2020 & 2028
                    6.3. Regional Market Share, 2020
                    6.4. North America
                         6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.4.2. U.S.
                              6.4.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.4.3. Canada
                              6.4.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                    6.5. Europe
                         6.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.5.2. U.K.
                              6.5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.5.3. Germany
                              6.5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.5.4. France
                              6.5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.5.5. Russia
                              6.5.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.5.6. Switzerland
                              6.5.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                    6.6. Asia Pacific
                         6.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.6.2. Japan
                              6.6.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.6.3. China
                              6.6.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.6.4. India
                              6.6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.6.5. Australia
                              6.6.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.6.6. South Korea
                              6.6.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                    6.7. Latin America
                         6.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.7.2. Brazil
                              6.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.7.3. Mexico
                              6.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                    6.8. MEA
                         6.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
                         6.8.2. South Africa
                              6.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                         7.1.1. Fresenius Kabi
                              7.1.1.1. Company overview
                              7.1.1.2. Financial performance
                              7.1.1.3. Product benchmarking
                              7.1.1.4. Strategic initiatives
                         7.1.2. Sino-Swed Pharmaceutical Corp., Ltd.
                              7.1.2.1. Company overview
                              7.1.2.2. Financial performance
                              7.1.2.3. Product benchmarking
                              7.1.2.4. Strategic initiatives
                         7.1.3. Hospira
                              7.1.3.1. Company overview
                              7.1.3.2. Financial performance
                              7.1.3.3. Product benchmarking
                              7.1.3.4. Strategic initiatives
                         7.1.4. Amanta Healthcare.
                              7.1.4.1. Company overview
                              7.1.4.2. Financial performance
                              7.1.4.3. Product benchmarking
                              7.1.4.4. Strategic initiatives
                         7.1.5. Otsuka Pharmaceutical Co., Ltd.
                              7.1.5.1. Company overview
                              7.1.5.2. Financial performance
                              7.1.5.3. Product benchmarking
                              7.1.5.4. Strategic initiatives
                         7.1.6. Sichuan Kelun Pharmaceutical Co., Ltd.
                              7.1.6.1. Company overview
                              7.1.6.2. Financial performance
                              7.1.6.3. Product benchmarking
                              7.1.6.4. Strategic initiatives
                         7.1.7. Terumo Corporation
                              7.1.7.1. Company overview
                              7.1.7.2. Financial performance
                              7.1.7.3. Product benchmarking
                              7.1.7.4. Strategic initiatives
                         7.1.8. Baxter
                              7.1.8.1. Company overview
                              7.1.8.2. Financial performance
                              7.1.8.3. Product benchmarking
                              7.1.8.4. Strategic initiatives
                         7.1.9. B. Braun Melsungen AG
                              7.1.9.1. Company overview
                              7.1.9.2. Financial performance
                              7.1.9.3. Product benchmarking
                              7.1.9.4. Strategic initiatives
                         7.1.10. Claris Lifesciences Ltd.
                              7.1.10.1. Company overview
                              7.1.10.2. Financial performance
                              7.1.10.3. Product benchmarking
                              7.1.10.4. Strategic initiatives
                         7.1.11. Kyowa Hakko Bio Co., Ltd.
                              7.1.11.1. Company overview
                              7.1.11.2. Financial performance
                              7.1.11.3. Product benchmarking
                              7.1.11.4. Strategic initiatives
                         7.1.12. Grifols
                              7.1.12.1. Company overview
                              7.1.12.2. Financial performance
                              7.1.12.3. Product benchmarking
                              7.1.12.4. Strategic initiatives
                         7.1.13. Liqvor Pharmaceuticals
                              7.1.13.1. Company overview
                              7.1.13.2. Financial performance
                              7.1.13.3. Product benchmarking
                              7.1.13.4. Strategic initiatives


List of Tables

Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global Intravenous (IV) Solutions Market, by Region 2016 - 2028 (USD Million)
Table 4 Global Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 5 Global Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 6 North America Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 7 North America Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 8 North America Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 9 U.S. Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 10 U.S. Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 11 Canada Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 12 Canada Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 13 Europe Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 14 Europe Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 15 Europe Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 16 U.K. Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 17 U.K. Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 18 Germany Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 19 Germany Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 20 France Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 21 France Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 22 Russia Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 23 Russia Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 24 Switzerland Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 25 Switzerland Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 26 Asia Pacific Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 27 Asia Pacific Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 28 Asia Pacific Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 29 Japan Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 30 Japan Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 31 China Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 32 China Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 33 India Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 34 India Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 35 Australia Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 36 Australia Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 37 South Korea Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 38 South Korea Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 39 Latin America Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 40 Latin America Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 41 Latin America Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 42 Brazil Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 43 Brazil Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 44 Mexico Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 45 Mexico Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 46 MEA Intravenous (IV) Solutions Market, by Country, 2016 - 2028 (USD Million)
Table 47 MEA Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million)
Table 48 MEA Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)
Table 49 South Africa Intravenous (IV) Solutions Market, by Type, 2016 - 2028 (USD Million))
Table 50 South Africa Intravenous (IV) Solutions Market, by Nutrients, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value - chain - based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Intravenous (IV) Solutions market :Market snapshot
Fig. 9 Intravenous (IV) Solutions market :Market segmentation
Fig. 10 Intravenous (IV) Solutions market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Intravenous (IV) Solutions market driver impact
Fig. 14 Intravenous (IV) Solutions market restraint impact
Fig. 15 Intravenous (IV) Solutions market porter’s five forces analysis
Fig. 16 Intravenous (IV) Solutions market PESTEL analysis
Fig. 17 Intravenous (IV) Solutions market segment dashboard
Fig. 18 Intravenous (IV) Solutions market: Type movement Analysis
Fig. 19 Total Parenteral Nutrition (TPN) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 20 Peripheral Parenteral Nutrition (PPN) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 21 Intravenous (IV) Solutions market segment dashboard
Fig. 22 Intravenous (IV) Solutions market: Nutrients movement Analysis
Fig. 23 Carbohydrates market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 24 Single Dose Amino Acid Solution market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Vitamins & Minerals (Salt and electrolyte) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 26 Other nutrients market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 27 Parenteral Lipid Emulsion market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 28 Global Intravenous (IV) Solutions market: Regional movement analysis
Fig. 29 Global market share, by region
Fig. 30 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Russia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 42 India market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Middle East and Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 South Africa market estimates and forecast, 2016 - 2028 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.